Yahoo Finance

Estimated Discount To Fair Value: 26.3%

Beijing Huafeng Test & Control Technology Ltd. is trading at CN¥104.5, well below its estimated fair value of CN¥141.81, reflecting potential undervaluation based on cash flows. The company reported nine-month revenue of CN¥621.2 million, up from CN¥518.73 million the previous year, with net income rising to CN¥213.09 million from CN¥197.06 million despite stable earnings per share figures. Expected annual profit growth is projected at 33.56%, surpassing market averages but return on equity remains modest at 13.1%.

• The growth report we've compiled suggests that Beijing Huafeng Test & Control TechnologyLtd's future prospects could be on the up.

• Dive into the specifics of Beijing Huafeng Test & Control TechnologyLtd here with our thorough financial health report.

Medley

Overview: Medley, Inc. operates platforms for recruitment and medical businesses in Japan and the United States, with a market cap of ¥124.58 billion.

Operations: The company's revenue is primarily derived from its Human Resource Platform Business at ¥19.45 billion and its Medical Platform Business at ¥6.52 billion, with additional contributions from New Services totaling ¥713 million.

Estimated Discount To Fair Value: 49.9%

Medley is trading at ¥3835, significantly below its estimated fair value of ¥7652.96, indicating undervaluation based on cash flows. Earnings are projected to grow 31.67% annually, outpacing the JP market's growth rate of 7.9%. Revenue growth is also expected to exceed market averages at 22.4% per year. However, recent financial results include large one-off items affecting earnings quality and share price volatility remains high over the past three months.

• Our expertly prepared growth report on Medley implies its future financial outlook may be stronger than recent results.

• Delve into the full analysis health report here for a deeper understanding of Medley.

Turning Ideas Into Actions

• Navigate through the entire inventory of 870 Undervalued Stocks Based On Cash Flows here.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ENXTAM:PNL SHSE:688200 and TSE:4480.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com